Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Eti Ishai"'
Publikováno v:
Basic & Clinical Pharmacology & Toxicology
Focal segmental glomerulosclerosis (FSGS) is a scarring process associated with chronic low‐grade inflammation ascribed to toll‐like receptor (TLR) activation and monocyte migration. We developed synthetic, small‐molecule lecinoxoids, VB‐201
Publikováno v:
The Journal of Immunology. 198:2125-2132
Binding of chemokines to their cognate receptors on monocytes instigates a cascade of events that directs these cells to migrate to sites of inflammation and cancerous tissues. Although targeting of selected chemokine receptors on monocytes exhibited
Autor:
Eti Ishai, Itzhak Mendel, Oshrat Propheta-Meiran, Anat Shoham, Erez Feige, Gideon Halperin, Eyal Breitbart
Publikováno v:
Journal of Neuroimmunology. 226:126-135
Oxidized phospholipids (Ox-PLs) are generated in abundance at sites of inflammation. Recent studies have indicated that Ox-PLs may also exhibit anti-inflammatory activities. In this study, we investigated the beneficial effect of VB-201, a pure synth
Publikováno v:
Journal of the Chemical Society, Perkin Transactions 1. :434-438
Reactions of trimethylsilyl-derived iodohydrins of the type R1R2CH–CH(I)OTMS, with electron-rich olefins, and the effects of certain factors on these reactions, were studied. The trimethylsilyl-derived iodohydrins were obtained in situ by reacting
Publikováno v:
ChemInform. 33
Reactions of trimethylsilyl-derived iodohydrins of the type R1R2CH–CH(I)OTMS, with electron-rich olefins, and the effects of certain factors on these reactions, were studied. The trimethylsilyl-derived iodohydrins were obtained in situ by reacting
Publikováno v:
Gastroenterology. 148:S-1059
Publikováno v:
Gastroenterology. 142:S-717
Publikováno v:
Digestive Diseases and Sciences
Background and Aims Previous studies demonstrated that toll-like receptors 4 and 2 (TLR-4 and TLR-2), which are expressed on liver-resident Kupffer, hepatic stellate cells, and circulating monocytes, play a role in nonalcoholic fatty liver disease. L